MARC details
000 -LEADER |
fixed length control field |
05580pam a2200481 i 4500 |
001 - CONTROL NUMBER |
control field |
019868507 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
Uk |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20221010170001.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
190926s2020 paua b 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2019043762 |
015 ## - NATIONAL BIBLIOGRAPHY NUMBER |
National bibliography number |
GBC0A2347 |
Source |
bnb |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
Record control number |
019868507 |
Source |
Uk |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781635930368 |
Qualifying information |
paperback |
Terms of availability |
£248.00 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Canceled/invalid ISBN |
9781635930375 |
Qualifying information |
ebook |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
StDuBDS |
Language of cataloging |
eng |
Transcribing agency |
StDuBDS |
Modifying agency |
Uk |
Description conventions |
rda |
042 ## - AUTHENTICATION CODE |
Authentication code |
ukblcatcopy |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RC271.C5 |
Item number |
C545 2019 |
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QZ 267 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
616.994061 |
Edition number |
23 |
245 00 - TITLE STATEMENT |
Title |
Clinical guide to antineoplastic therapy : |
Remainder of title |
a chemotherapy handbook / |
Statement of responsibility, etc. |
Edited by Mary Magee Gullatte, PhD, RN, ANP-BC, AOCN, LSSYB, FAAN, Rowena Schwartz, PharmD, BCOP, FHOPA, Rowena Schwartz, PharmD, BCOP, FHOPA, Renee Spinks, MSN, APRN, ACNS-BC, AOCNS, Deborah Kirk Walker, DNP, FNP-BC, NP-C, AOCN, FAANP. |
250 ## - EDITION STATEMENT |
Edition statement |
Fourth edition. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Pittsburgh, PA : |
Name of producer, publisher, distributor, manufacturer |
Oncology Nursing Society, |
Date of production, publication, distribution, manufacture, or copyright notice |
[2020] |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xix, 1232 pages : |
Other physical details |
illustrations ; |
Dimensions |
26 cm |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Media type code |
n |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Carrier type code |
nc |
Source |
rdacarrier |
500 ## - GENERAL NOTE |
General note |
Formerly CIP. |
Institution to which field applies |
Uk |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Cellular mechanisms of chemotherapy -- Pharmacologic principles of chemotherapy -- Pharmacogenomics and chemotherapy -- Principles and standards of antineoplastic therapy administration -- Administration of hazardous drugs in the perioperative setting -- Immunotherapy : agents and targets -- Targeted therapy : small molecule inhibitors -- Antineoplastic agents -- Antineoplastic regimens -- Stem cell transplantation science and practice -- Clinical trials -- Strategies to improve adherence to oral cancer therapies -- Symptom management -- Intimacy and sexuality concerns of patients receiving chemotherapy -- Late effects of chemotherapy -- Cancer survivorship support -- Maximizing outpatient reimbursement for antineoplastic agents -- Legal issues in cancer care -- Complementary and alternative medicine therapies in oncology practice -- Botanicals in cancer care -- Access devices -- Biosimilars -- Improving patient care outcomes through navigation -- Patient and family support during and after cancer therapy -- Public and professional cancer resources. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
"The world of cancer treatment is changing almost daily. In 2018 alone, the U.S. Food and Drug Administration approved 19 new cancer drug treatments, and many more promising drugs are on the horizon. New therapies include targeted therapies, immunotherapy, drugs associated with cancer genetics, and nanotechnology. A developing treatment is CAR (chimeric antigen receptor) T-cell therapy, which includes the administration of new immunotherapy drugs used for adult patients with certain types of lymphoma and for children and young adults with acute lymphoblastic leukemia. Virtually every single chemotherapy drug comes with its own long list of symptoms, which are only confounded when more than one agent is used in a cancer regimen. Oncology nurses are almost always the providers who intervene when patients experience one or many symptoms; thus, these professionals must remain knowledgeable about the effects of all antineoplastic agents in use.Many of the newer medications have associated symptoms such as skin alterations and intense flu-like symptoms that, until recently, were not the usual mainstay. This handbook was written by a collection of expert oncology professionals to address every facet of antineoplastic therapy, from understanding biomarkers that influence treatment decisions, navigating cost and reimbursement issues, to supporting patients and their families throughout their treatment trajectory and survivorship. A team of nurses, pharmacists, advanced practice providers, social workers, and physicians have contributed to this text and reflects the collaborative nature of the delivery of care to patients. Chapters examine antineoplastic agent use and monitoring, from conventional cytotoxic chemotherapy to clinical trials and survivorship, and include detailed drug monographs for quick access to information.New perspectives and topics, such as biosimilars, help providers appreciate the nuances of the expanding categories of antineoplastic agent use. The approach of including scientific, operational, and psychosocial information across topics ensures the reader gains global information to ideally expand knowledge, increase curiosity, and aid in delivering exceptional care. Similarly, holistic topics, including support services, patient navigation, access devices, and legal concerns provide, a well-rounded approach to subject matter relevant to all disciplines involved in care. This edition of A Chemotherapy Handbook is a key resource for everyone from newly minted practitioners to seasoned veterans involved in oncology patient management"-- |
Assigning source |
Provided by publisher. |
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE |
Additional physical form available note |
Also issued online. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Cancer |
General subdivision |
Chemotherapy. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Neoplasms |
General subdivision |
drug therapy. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Antineoplastic Agents |
General subdivision |
therapeutic use. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Gullatte, Mary Magee, |
Relator term |
editor. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Schwartz, Rowena, |
Relator term |
editor. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Spinks, Renee, |
Relator term |
editor. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Walker, Deborah Kirk, |
Relator term |
editor. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
Oncology Nursing Society, |
Relator term |
issuing body. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Relationship information |
Online version: |
Title |
Clinical guide to antineoplastic therapy |
Edition |
Fourth edition. |
Record control number |
(DLC) 2019043763 |
Place, publisher, and date of publication |
Pittsburgh : Oncology Nursing Society, [2019] |
International Standard Book Number |
9781635930375 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
National Library of Medicine |